Chitosan induced hepato-nephrotoxicity in mice with special reference to gender effect in glycolytic enzymes activities

Regulatory Toxicology and Pharmacology

Volumn 62, Issue 1, 2012, Pages 29-40

  Omara, Enayat A ^a   Aly, Hanan F ^a   Nada, Somaia A ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Biochemical; Chitosan; Histochemical; Histopathological; Mice

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHITOSAN; CREATININE; GLUCOSE 6 PHOSPHATE ISOMERASE; GLYCOGEN; GLYCOLYTIC ENZYME; HEXOKINASE; LACTATE DEHYDROGENASE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; LIVER TOXICITY; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; SEX DIFFERENCE; UREA BLOOD LEVEL;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CHITOSAN; CREATININE; FEMALE; GLYCOGEN; KIDNEY; LIPIDS; LIVER; MALE; MICE; SEX FACTORS; UREA;

MUS;

EID: 84855513375     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2011.11.010     Document Type: Article

References (50)

1. Ahmed S.G., Gad M.Z. Effect of schistosomal infection and its treatment on some key enzymes of glucose metabolism in mice livers. Arzneimittelforschung 1995, 45:1324-1330.
2. Ausar S.F., Morcillo M., Leon A.E., Ribotta P.D., Bianco I.D. Improvement of HDL and LDL-cholesterol levels in diabetic subjects by feeding bread containing chitosan. J. Med. Food 2003, 6:397-399.
3. Babson A.L., Babson S.R. Kinetic colorimetric measurement of serum lactate dehydrogenase activity. Clin. Chem. 1973, 19:766.
4. Bancroft J.D., Gamble M. Theory and Practice of Histological Techniques 2002, Churchill Livingstone Pub., Edinburgh, (pp. 172-175, 593-620). fifth ed.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
6. Cohen D.E. Cholesterol absorption as a target for lipid-lowering therapy. Formulary 2004, 39:3-7.
7. Fawcett J.K., Soctt J.E. Urease-Berthelot method. J. Clin. Pathol. 1960, 13:156-159.
8. Fernandez M.I., Vergara-Jimenez M., Romero A.L., Erickson S.K., McNamara D.J. Gender differences in response to dietary soluble fiber in guinea pig: effect of pectin, guar gum, and psyllium. J. Lipid Res. 1995, 36:2191-2202.
9. Friedewald W.T. Total triglycerides, total cholesterol and high densitylipoprotein cholesterol assays. Clin. Chem. 1972, 18:499.
10. Hassid W.Z., Abraham S. Chemical procedures for analysis of polysaccharides. Methods in Enzymology 1957, vol. 3:34-37. Academic Press, New York.
11. y mice. Biol. Pharm. Bull. 2000, 25:188-192.
12. He X.B., Xue C.K. Experimental study of the hepatoprotective effect of chitosan. Herald Med. 2004, 23:45-65.
13. Henry, R.J., 1974. Creatinine colorimetric method. In: Clinical Chemistry. Principles and Techniques, second ed. Harper and Row, p. 525.
14. Hossain S., Rahman A., Kabir Y., Shams A.A., Afrose F., Hashimoto M. Effect of shrimp (Macrobracium rosenbergii) - derived chitosan on plasma lipid profile and liver lipid peroxide level in normo- and hypercholesterolaemic rats. Clin. Exp. Pharmacol. Physiol. 2007, 34:170-176.
15. Imogen M., Julia W., Sarah F., Roger W. Anti-tuberculous therapy and acute liver failure. Lancet 1995, 345:555-556.
16. Kind P.R., King E.J. Estimation of plasma phosphatase by determination of hydrolysed phenol (with-antipyrine). J. Clin. Phathol. 1954, 7:322.
17. King, J., 1965. Glucose phosphate isomerase. In: Practical Clinical Enzymology, D. Van Nostr and Co. Ltd., London, pp.1113-1117.
18. Koide S.S. Chitin-chitosan: properties, benefits and risks. Nutr. Res. 1998, 18:1091-1101.
19. Landes D.R., Bough W.A. Effects of chitosan - a coagulating agent for food processing wastes in the diets of rats - on growth and liver and blood composition. Bull. Environ. Contam. Toxicol. 1976, 15(5):555-563.
20. Lee C.E., Koh D.H., Chang Y.M., Kim K.I. Effects of sex and diets containing alfalfa, laver or pine-needle meals on the plasma cholesterol level in rats. Nutr. Sci. 1999, 2:46-50.
21. Lee C.E., Kang J., Klim K. Effect of gender, gonadectomy and sex hormones on growth and plasma cholesterol level in rats. Ann. Nutr. Metab. 2008, 53:1-5.
22. Miura T., Usami M., Tsuura Y., Ishida H., Seino Y. Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin-induced diabetic mice. Biol. Pharm. Bull. 1995, 18:1623-1625.
23. Muzzarelli, R.A.A., 1977. Enzymatic synthesis of chitin and chitosan. Occurrence of chitin. In: Chitin. Pergamon Press, New York, NY, pp. 5-17.
24. Ormrod D.J., Holmes C.C., Miller T.E. Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E deficient mouse model of atherosclerosis. Atherosclerosis 1998, 138:329-334.
25. Orr, A., 1999. Another New Diet Craze? [ ]. http://www.sizeacceptance.org/news/news055.html.
26. Paget, G.E., Barnes, J.M., 1964. Interspecies dosage conversion scheme in evaluation of results and quantitative application in different species. In: Laurence, D.R., Bacharach, A.L. (Eds.) " Evaluation of Drug Activities: Pharmacometrics" , vol. 1. Academic press, London and New York, pp. 160-162.
27. Razdan A., Pettersson D. Hypolipidaemic, gastrointestinal and related responses of broiler chickens to chitosans of different viscosity. Br. J. Nutr. 1996, 76:387-397.
28. Razdan A., Pettersson D., Pettersson J. Broiler chicken body weights, feed intakes, plasma lipid and small-intestinal bile acid concentrations in response to feeding of chitosan and pectin. Br. J. Nutr. 1997, 78:283-291.
29. Reitman S., Frankel S. Determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol. 1957, 28:56-60.
30. Rudling M., Angelin B. Loss of resistance to dietary cholesterol in the rat after hypophysectomy: importance for hepatic low density lipoprotein-receptor expression. Proc. Natl. Acad. Sci. USA 1993, 90:8851-8855.
31. Santhosh S., Sini T.K., Anandan R., Mathew P.T. Hepatoprotective activity of chitosan against experimental rats. Eur. J. Pharmacol. 2007, 572:69-73.
32. Senel S., McClure S.J. Potential applications of chitosan in veterinary medicine. Adv. Drug. Deliver. Rev. 2004, 56:1467-1480.
33. Stein E.A., DiPersio L., Peace A.J., Kashyap M., Kao J., Srivastava L., McNemey C. Enzyme-linked immunoabsorbant assay of apolipoprotein all in plasma, with use of a monoclonal antibody. Clin.Chem. 1986, 32(6):967-971.
34. Sudhahar V.S.A., Kumar P.T., Sudharsan S., Varalakshmi P. Protective effect of lupeol and its ester on cardiac abnormalities in experimental hypercholesterolemia. Vascul. Pharmacol. 2007, 46:412-418.
35. Sumiyoshi M., Kimura Y. Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet long-term in mice. J. Pharm. Pharmacol. 2006, 58:201-207.
36. Tanaka Y., Tanioka S., Tanaka M., Tanigawa T., Kitamura Y., Minami S., Okamoto Y., Miyashita M., Nanno M. Effects of chitin and chitosan particles on BALB/c mice by oral and parenteral administration. Biomaterials 1997, 18(8):591-595.
37. Tielens A.G. Biochemistry of trematode. Advances in Trematode Biology 1997, 309-343. CRC Press, Bocaraton. B. Fried, T.K. Graczyk (Eds.).
38. Tozaki H., Komoie J., Tada C., Maruyama T., Terabe A., Suzuki T., Yamamoto A., Muranishi S. Chitosan capsules for colon specific drug delivery: improvement of insulin absorption from of rat colon. J. Pharm. Sci. 1997, 86:1016-1021.
39. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J. Clin. Pathol. 1969, 22:158-161.
40. Tsung Y.H., Tsan C.M. Plasma lipoprotein cholesterol in rats fed a diet enriched in chitosan and cholesterol. J. Nutr. Sci. Vitaminol. 2002, 48:379-383.
41. Uyeda K., Racker E. Regulatory mechanisms in carbohydrate metabolism. VII. Hexokinase and phosphofructokinase. J. Biol. Chem. 1965, 240:4682.
42. van Bennekum A.M., Nguyen D.V., Schulthess G., Hauser H., Phillips M.C. Mechanisms of cholesterol-lowering effects of dietary insoluble fibres: relationships with intestinal and hepatic cholesterol parameters. Br. J. Nutr. 2005, 94:331-337.
43. Wahlefeld, A.W., 1974. In: Bergmeyer, H.U. (Ed.), Method of Enzymatic Analysis, vol. 5, Academic Press, New York, pp. 1831-1835.
44. Xiao-hong Q., Zhang Z.P., Li X.Y., Que L.L., Wu C.Z. Therapeutic effect and mechanisms of chitosan compound on rats of experimental fatty liver. Zhongguo Xinyao Yu Linchuang Zazhi 2004, 23:283-286.
45. Xing R., Liu S., Guo Z., Yu H., Wang P., Li C., Li Z., Li P. Relevance of molecular weight of chitosan and its derivatives and their antioxidant activities in vitro. Bioorg. Med. Chem. 2005, 13:1573-1577.
46. Yao H.T., Lii C.K., Chou R.H., Lin J.H., Yang H.T. Effect of chitosan on hepatic drug-metabolizing enzymes and oxidative stress in rats fed low- and high-fat diets. Agric. Food Chem. 2010, 58(8):5187-5193.
47. Ylitalo R., Lehtinen S., Wuollijoki E., Ylitalo P., Lehtimaki T. Cholesterol-lowering properties and safety of chitosan. Arzneimittel-Forschung-Drug Res. 2002, 52:1-7.
48. Zammit V.A., Beis I., Newsholme E.A. Maximum activities and effects of fructose biphosphate on pyruvate kinase from muscles of vertebrates and invertebrates in relation to the control of glycolysis. Biochem. J. 1978, 174:989.
49. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.
50. Zollner N., Kirsch K. Total lipids colorimetric method. Z. Ges. Exp. Med. 1962, 135:545.